By Sara Heath March 02, 2023 – A new study out of Tulane University confirms what many may have been able to guess about patient access to care: paid sick leave policies…
Continue Reading
By John Halamka and Paul Cerrato — With over 10,000 mental health apps available, it’s difficult to know which ones will actually have a therapeutic impact. Fortunately, enough high-quality evidence is available to help…
Continue Reading
Multinational pharmaceutical and biotech company Pfizer and AI-powered data company Tempus announced a multi-year strategic alliance to utilize AI and machine learning to inform drug discovery and development in oncology. Pfizer will leverage Tempus’ library…
Continue Reading
Sponsored by Consensus Cloud Solutions
March 02, 2023 – Health data exchange between providers is key to ensuring that patients receive the most appropriate care possible based on the best available information.
Over the last decade,…
Outside of common conditions, most doctors see only a few cases of some problem in their entire career. That's why students and residents gather eagerly around hospital patients who were diagnosed with a rare…
Continue Reading
As a health economist, researcher in evidence-based medicine, and consultant to biopharma executives, I am no stranger to data. We all want more of it, to make sense of it, and to use it…
Continue Reading
Eli Lilly is cutting insulin prices, and this time it’s for real.
Months after a Twitter account posing as the drugmaker went viral with a tweet stating, “insulin is free now,” the company on Wednesday…
Scientists at the University of Massachusetts Amherst have developed a biosensor that is based on protein nanowires that are created by bacteria. The protein nanowires are highly sensitive to ammonia, in this case, which…
Continue Reading
The HIMSS EHR Association this week sent a letter asking the Centers for Medicare and Medicaid Services to extend the comment period on its Advancing Interoperability and Improving Prior Authorization Processes proposed rule by…
Continue Reading
Prescription digital therapeutic developer Theranica announced it had received FDA 510(k) clearance to use its Nerivio device for migraine prevention in patients 12 and older. The wearable is worn around the upper arm and controlled…
Continue Reading
